Merck KGaA puts CAR T development in Intrexon's hands

By Jennie Walters | Dec 20, 2018 | 10:54 PM GMT

Merck KGaA (Xetra:MRK) has become the latest pharma to realize early stage CAR T technologies may be best in the hands of smaller companies after transferring to